The role of canonical WNT signaling pathway in oral carcinogenesis: A comprehensive review

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 873-878

  Noguti, Juliana ^a   De Moura, Carolina Foot Gomes ^a   Hossaka, Thais Ayako ^a   Franco, Marcello ^a   Oshima, Celina Tijuko Fujiyama ^a   Dedivitis, Rogerio Aparecido ^b   Ribeiro, Daniel Araki ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ANA COSTA   (Brazil)

Author keywords

Apoptosis; Oral cancer; Review; WNT

Indexed keywords

WNT PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL ACTIVITY; HUMAN; MOUTH CANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84858757252     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Magrath I and Litvak J: Cancer in developing countries: opportunity and challenge. J Nat Cancer Inst 85: 862-874, 1993. (Pubitemid 23157126)
2. Lese C, Rossie K, Appel B, Reddy J, Johnson I and Myers E: Visualization of INT2 and HST1 amplification in oral squamous cell carcinoma. Genes Chromosomes Cancer 12: 288-295, 1995.
3. Rodrigues V, Moss S and Tuomainen H: Oral cancer in the UK to screen or not to screen?. Oral Oncol 34: 454-465, 1998.
4. Xi S and Grandis J: Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82: 11-16, 2003
5. Berenson J, Yang I and Mickel R: Frequent amplification of the BCL-1 locus in head and neck squanous cell carcinomas. Oncogene 4: 1111-1116, 1989. (Pubitemid 19211726)
6. Logan C and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
7. Johnson M, and Rajamannan N: Diseases of Wnt signaling. Rev Endocr Metab Disord 7: 41-49, 2006. (Pubitemid 46044348)
8. Mlodzik M: Planar cell polarization: Do the same mechanisms regulate drosophila tissue polarity and vertebrate gastrulation? Trends Genet 18: 564-571, 2002.
9. +2 pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283, 2000.
10. Chen A, Ginty D and Fan C: Protein kinase a signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433: 317-322, 2005.
11. Muzio LL, Goteri G and Capretti R: Beta-catenin gene analysis in oral squamous cell carcinoma. Int J Immunopathol Pharmacol 18: 33-38, 2005.
12. Gordon M and Nusse R: Wnt signaling: multiple pathways, multiple receptors and multiple transcription factors. J Biol Chem 281: 22429-22433, 2006.
13. Muzio LL, Staibano S, Pannone G, Grieco M, Mignani M, Cerrato A, Testa N and Rosa GD: β- and γ-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826, 1999.
14. Muzio ML: WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of β-catenin. AntiCancer Res 22: 565-576, 2002.
15. Fracalossi A, Silva M, Oshima C and Ribeiro D: Wnt/β-catenin signalling pathway following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Mol Pathol 88: 176-183, 2010.
16. Kerr J, Wyllie A and Currie A: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
17. Kerr J: History of the events leading to the formulation of the apoptosis concept. Toxicology 181-182: 471-474, 2002.
18. Evan G and Vousden K: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001. (Pubitemid 32467043)
19. Cecconi F, Alvarez-Bolado G, Meyer B, Roth K and Gruss P: Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727-737, 1998. (Pubitemid 28436005)
20. Yoshida H, Kong Y, Yoshida R, Elia A, Hakem A, Hakem R, Penninger J and Mak T: Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739-750, 1998. (Pubitemid 28436006)
21. Aravind L, Dixit V and Koonin E: The domains of death: Evolution of the apoptosis machinery. Trends Biochem Sci 24: 47-53, 1999. (Pubitemid 29346572)
22. Tsujimoto Y, Jafee E, Cossman J, Gorham J, Nowell P and Croce C: Clustering of breaking points on chromosome 11 in human B-cell neoplasms with the t(11,14) translocation. Nature 315: 340-343, 1985. (Pubitemid 15044628)
23. Lu Q, Abel P, Foster C and Lalani E: BCL-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102-110, 1996. (Pubitemid 26049462)
24. Oltvai Z, Milliman C and Korsmeyer S: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
25. Krajewska M, Fenoglio-Preiser C, Krajewski S, Song K, Macdonald J, Stemmerman G and Reed J: Immunohistochemical analysis of BCL-2 family proteins in adenocarcinomas of the stomach. Am j Pathol 149: 1449-1457, 1996. (Pubitemid 26363951)
26. Yao L, Iwai M and Furuta I: Correlations of BCL-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncology 35: 56-62, 1999. (Pubitemid 28546845)
27. Nishimura A: Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J Dent Res 78: 1264-1269, 1999.
28. Ribeiro D, Salvadori D and Marques M: Abnormal expression of Bcl-2 and Bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Int J Exp Pathol 86: 375-381, 2005. (Pubitemid 41746376)
29. Minicucci E, Ribeiro D, Silva GN, Pardini M, Montovani J and Salvadori D: The role of the TP53 gene during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Toxicol Pathol 63: 483-489, 2011.
30. Dash P: http://wwwsgulacuk/depts/immunology/~dash/apoptosis/2008.
31. Simonis M, Klous P, Splinter E, Moshkin Y, Willemsen R, Wit ED, Steensel BV and Laat WD: Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat Genet 38: 1348-1354, 2006. (Pubitemid 44646300)
32. Kaur J and Sanyal S: PI3-kinase/Wnt association mediates COX-2/PGE-2 pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac. Tumor Biol 31: 623-631, 2010.
33. Yeo W and Gautier J: Early neural cell death: dying to become neurons. Dev Biol 274: 233-244, 2004. (Pubitemid 39295718)
34. Brocardo M and Henderson B: APC shuttling to the membrane, nucleus and beyond. Trends Cell Biol 18: 587-596, 2008.
35. Li F, Chong Z and Maiese K: Winding through the WNT pathway during cellular development and demise. Histol Histopathol 21: 103-124, 2006. (Pubitemid 43033719)
36. Crowder R and Freeman R: Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3- kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275: 34266-34271, 2000.
37. Ellies D, Church V, Francis-West P and Lumsden A: The WNT antagonist cSFRP2 modulates programmed cell death in the developing hindbrain. Development 127: 5285-5295, 2000. (Pubitemid 32049185)
38. Zheng W, Kar S and Quirion R: Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by AKT kinase in PC12 cells. J Biol Chem 275: 39152-39158, 2000. (Pubitemid 32058931)
39. Manoukian A and Woodgett J: Role of glycogen synthase kinase 3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 84: 203-229, 2002. (Pubitemid 34188198)
40. Shakoori A, Ougolkov A, Yu Z, Zhang B, Modarressi M and Billadeau D: Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 334: 1365-1373, 2005. (Pubitemid 41074725)
41. Chao DT and Korsmeyer SJ: BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419, 1998. (Pubitemid 28183370)
42. Green D and Reed J: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)
43. Liu X, Kim C, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996. (Pubitemid 26256586)
44. Chen S, Guttridge D, You Z, Zhang Z, Fribley A, Mayo M, Kitajewski J and Wang C: Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 152: 87-96, 2001. (Pubitemid 32102439)
45. Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, Alnemri E and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1996. (Pubitemid 27508237)
46. Zou H, Henzel W, Liu X, Lutschg A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997. (Pubitemid 27347231)
47. Morin P, Vogelstein B and Kinzler K: Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-7954, 1996. (Pubitemid 26277145)
48. TC He, Chan T, Vogelstein B and Kinzler K: PPAR is an APC regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
49. Orford K, Orford C and Byers S: Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146: 855-886, 1999.
50. Strovel E and Sussman D: Transient overexpression of murine dishevelled genes results in apoptotic cell death. Exp Cell Res 253: 637-648, 1999. (Pubitemid 30003125)
51. Johnson B, Cepero E and Boise L: Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha. J Biol Chem 6: 31546-31553, 2000.
52. Zhang S, Kovalenko A, Cantarella G and Wallach D: Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12:n301, 2000.
53. You Z, Saims D, Chen S, Zhang Z, Guttridge D, Guan K, MacDougald O, Brown A, Evan G, Kitajewski J and Wang C: Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 29: 429-440, 2002. (Pubitemid 34839807)
54. Pećina-Šlaus N, Majić Z, Musani V, Zeljko M and Xupić H: Report on mutation in exon 15 of the APC gene in a case of brain metastasis. Neurooncol 97: 143-148, 2010.
55. Chen T, Yang I, Irby R, Shain K, Wang H, Quackenbush J, Coppola D, Cheng J and Yeatman T: Regulation of caspase expression and apoptosis by adenomatous polyposis coli. Cancer Res 63: 4368-4374, 2003. (Pubitemid 36951005)
56. Hasegawa S, Sato T, Akazawa H, Okada H, Maeno A, Ito M, Sugitani Y, Shibata H, Miyazaki J, Katsuki M, Yamauchi Y, Yamamura K, Katamine S and Noda T: Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene. Proc Natl Acad Sci USA 99: 297-302, 2002. (Pubitemid 34060357)
57. Mogensen M, Tucker J, Mackie J, Prescott A and Nathke I: The adematous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved estabilishing parallel arrays of microtubules bundles in highly polarized epithelial cells J Cell Biol 157: 1041-1048, 2002. (Pubitemid 34839778)
58. Uraguchi M, Morikawa M, Shirakawa M, Sanada K and Imai K: Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 83: 327-332, 2004. (Pubitemid 41713770)
59. Iwai S, Katagiri W, Amekawa C, Nakazawa M and Yura Y: Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 131: 773-782, 2005. (Pubitemid 41630700)
60. El-Bahrawy M, El-Masry N, Alison M, Poulsom R and Fallowfield M: Expression of beta-catenin in basal cell carcinoma. Br J Dermatol 148: 964-970, 2003. (Pubitemid 36750789)
61. Pannone G, Muzio LL, Bucci P, Canfora M, Pannone G, Santacroce L, Bucci T and Staibano S: Physiopathology of β and χ-catenin expression in the oral epithelium. Minerva Stomatol 47: 583-588, 1998.
62. Lyakhovitsky A, Barzilai A, Fogel M, Trau H and Huszar M: Expression of E-cadherin and β-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol 26: 372-378, 2004. (Pubitemid 39287357)
63. Laxmidevi L, Angadi P, Pillai R and Chandreshekar C: Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: an immunohistochemical study. J Oral Sci 52(4): 633-640, 2010.
64. Schussel J, Jr DP and Martins M: Altered β-catenin expression related to cancer progression on actinic cheilitis and squamous cell carcinoma of the lip. Ann Diag Pathol 15: 1-5, 2011.
65. Mahomed F, Altini M and Meer S: Altered E-cadherin/(beta)-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis 13: 386-392, 2007. (Pubitemid 46934571)
66. Cai Z, Shi X, Gao Y, Wei M, Wang C and Yu G: β-catenin expression pattern in primary oral squamous cell carcinoma. Chin Med J 121: 1866-1870, 2008.
67. Kildal A: β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer, a study in 253 patients. Eur J Cancer 41: 1127-1134, 2005.
68. Gamallo C, Palacios J, Moreno G, Mora JCd, Suárez A and Armas A: β-catenin expression pattern in stage I and II ovarian carcinomas, relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155: 527-536, 1999. (Pubitemid 29370402)
69. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan P and Yang Y: Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162: 899-908, 2003. (Pubitemid 37087729)
70. Davies B, Worsley S and Ponder B: Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 32: 69-80, 1998.
71. Boynton R, Blount P, Yin J, Brown V, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau J, Raskind W, Haggitt R, Reid B and Meltzer S: Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 89(8): 3385-3388, 1992.
72. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki T, Mori T and Nakamura Y: Somatic mutations of the APC gene in colorectal tumors: mutation cluster resion in the APC gene. Hum Mol Genet 1(4): 229-233, 1992.
73. Pannone G, Bufo P, Santoro A, Franco R, Aquino F, Longo G, Botti G, Serpico R, Cafarelli B, Abbruzze A, Caraglia M, Papageraki S and LoMuzio L: WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors. Oncol Rep 24: 1035-1041, 2010.
74. Mir MM, Dar JA, Dar NA, Syed AT, Salam I and Lone GN: The association of beta-catenin gene mutations and human papillomavirus in carcinoma of esophagus in a high-risk population of India. Int J Health Sci (Qassim) 1: 177-183, 2007.
75. Ninomiya I, Endo Y, Fushida S, Sasagawa T, Miyashita T, Fujimura T, Nishimura G, Tani T, Hashimoto T, Yagi M, Shimizu K, Ohta T, Yonemura Y, Inoue M, Sasaki T and Miwa K: Alteration of β-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 85(6): 757-761, 2000. (Pubitemid 30131461)
76. Yeh K, Chang J, Lin T, Wang Y, Chang Y, Shih M and Lin C: Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol 23(4): 1001-1007, 2003.
77. Nusse R, Ooyen Av, Cox D, Fung Y and Varmus H: Mode of proviral activation of a putative mammary oncogene (INT-L) on mouse chromosome 15. Nature 307: 131-136, 1984. (Pubitemid 14132897)
78. Brown A, Wildin R, Prendergast T and Varmus H: A retrovirus vector expressing the putative mammary oncogene INT-L causes partial transformation of a mammary epithelial cell line. Cell 46: 1001-1009, 1986. (Pubitemid 17182724)
79. Papkoff J, Rubinfeld B, Schryver B and Polakis P: Wnt-I regulates free pools of catenins and stabilizes APC catenin complexes. Mol Cell Biol 16: 2128-2134, 1996. (Pubitemid 26123733)
80. Muzio LL: A possible role for the Wnt-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med 12: 152-165, 2001.
81. Rhee C: Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598-6605, 2002.
82. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo M, and Oshima M: Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 131: 1086-1095, 2006. (Pubitemid 44498691)
83. Bahnot O, Brink M, Samos S, Hsieh J, Wang Y, Macke J, Andrew D, Nathans J and Nusse R: A new member of the frizzled family from Drosophila functions as a Wingless receptor. Natue 18(382(6588)): 225-230, 1996.
84. Prado S, Villaamil V, Gallego G, Calvo M, Cedrún J, Soliva S, Ayerbes M, Campelo R and Aparicio L: Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas. Virchows Arch 455: 67-75, 2009.
85. Zilberberg A, Yaniv A and Gazit A: The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J Biol Chem 279: 17535-17542, 2004. (Pubitemid 38560517)